Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors.
- Resource Type
- journal article
- Source
- Journal of Thoracic Oncology; Feb2022, Vol. 17 Issue 2, p277-288, 12p
- Subject
- Language
- ISSN
- 15560864